MIRANDA NJANTE: Open Payments
NPI 1649884065 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$708 in 26 payments from 7 companies in 2025. Trend: 2023 $44 · 2024 $0 · 2025 $708
Food & beverage: $596Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 17 | $495 |
| Alkermes, Inc. | 2 | $58 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 1 | $34 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Noven Therapeutics, LLC | 1 | $19 |
Products named: AUSTEDO XR, UZEDY, LYBALVI, FANAPT, ABILIFY MAINTENA, COBENFY, CAPLYTA, Xelstrym.
Industry payments across AZ — which companies pay providers there.
